Multi-modality treatment of primary nonresectable intrahepatic cholangiocarcinoma with 131I anti-cea—A radiation therapy oncology group study
- 1 May 1987
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 13 (5) , 687-695
- https://doi.org/10.1016/0360-3016(87)90286-0
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Phase II trial of m-AMSA in gallbladder and cholangiocarcinoma: a Southwest Oncology Group StudyEuropean Journal of Cancer and Clinical Oncology, 1983
- Epithelial membrane antigen expression in cholangiocarcinomaVirchows Archiv, 1983
- Malignancies in Portuguese Thorotrast PatientsHealth Physics, 1978
- Mitomycin C: a reviewCancer Treatment Reviews, 1976
- CholangiocarcinomaA clinicopathologic study of five cases with ultrastructural observationsHuman Pathology, 1974
- Primary liver cancer.A review of the clinical features, blood groups, serum enzymes, therapy, and survival of 65 casesCancer, 1974
- Adenocarcinomas of stomach, pancreas, liver, and biliary tracts.Survival of 328 patients treated with fluoropyrimidine therapyCancer, 1974
- Primary carcinoma of the liver: A study of 282 cases in Ugandan AfricansThe Journal of Pathology, 1973
- 5-fluorouracil given once weekly: Comparison of intravenous and oral administrationCancer, 1971
- Primary carcinoma of the liver.A study of 100 cases among 48,900 necropsiesCancer, 1954